Notable Put Options Activity in Celldex Therapeutics
Shares of Celldex Therapeutics (NASDAQ: CLDX) are higher on the session by 0.82%, currently trading at $8.56. The stock has been moving largely lower over the past three weeks and is currently trading above the 50-day moving average.
Options traders are focusing on puts today. The strike seeing the heaviest action is the May 2012 $3.00 put, which has traded 2,500 times on open interest of 2,781 contracts.
The block traded at $0.10.
Put volume is outpacing call volume by 5 to 1.
Celldex Therapeutics, Inc. is a biopharmaceutical company, which applies its Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.